Literature DB >> 6626263

Methionine synthesis from 5'-methylthioadenosine by tumour cells.

M J Tisdale.   

Abstract

Incubation of cytosolic fractions of some tumour and normal cell lines with 5'-methylthioadenosine (5'-MTA) resulted in the formation of methionine. Methionine formation only occurred in those cell lines possessing 5'-MTA phosphorylase. The kinetics of product formation indicated that 5'-MTA was first rapidly converted into 5-methylthioribose-1-phosphate, followed by its slower conversion into methionine. Methionine synthesis from 5'-MTA was increased in cells previously incubated in methionine-depleted medium supplemented with 0.1 mM L-homocysteine for 24 hr. For most cell lines methionine synthesis from 5'-MTA was linear for only a short time period, and was followed by a first order decrease in the rate of methionine synthesis. Methionine synthesized from 5'-MTA was extensively incorporated into cellular macromolecules suggesting that 5'-MTA may substitute for methionine as a one-carbon source. This was confirmed by growth experiments which showed that low concentrations of 5'-MTA could partially substitute for methionine for some, but not all, cell lines. Higher concentrations of 5'-MTA were growth inhibitory. It may be possible to use 5'-MTA to selectively 'rescue' cells from methionine deprivation produced by the enzyme L-methioninase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6626263     DOI: 10.1016/0006-2952(83)90396-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Intracellular metabolism of beta-L-2',3'-dideoxyadenosine: relevance to its limited antiviral activity.

Authors:  L Placidi; E Cretton-Scott; G Gosselin; C Pierra; R F Schinazi; J L Imbach; M H el Kouni; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 2.  Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies.

Authors:  Joseph R Bertino; William R Waud; William B Parker; Martin Lubin
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

3.  Deletion of MTAP Highly Sensitizes Osteosarcoma Cells to Methionine Restriction With Recombinant Methioninase.

Authors:  Yusuke Aoki; Yasunori Tome; Qinghong Han; Jun Yamamoto; Kazuyuki Hamada; Noriyuki Masaki; Yutaro Kubota; Michael Bouvet; Kotaro Nishida; Robert M Hoffman
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

4.  Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.

Authors:  Sarah Franco Vieira de Oliveira; Monica Ganzinelli; Rosaria Chilà; Leandro Serino; Marcos Euzébio Maciel; Cícero de Andrade Urban; Rubens Silveira de Lima; Iglenir João Cavalli; Daniele Generali; Massimo Broggini; Giovanna Damia; Enilze Maria de Souza Fonseca Ribeiro
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

5.  Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.

Authors:  Martin Lubin; Adam Lubin
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

6.  Characterization and Prognostic Significance of Methylthioadenosine Phosphorylase Deficiency in Nasopharyngeal Carcinoma.

Authors:  Hong-Lin He; Ying-En Lee; Yow-Ling Shiue; Sung-Wei Lee; Tzu-Ju Chen; Chien-Feng Li
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.